Engineering Immune Effector Cells from iPSCs: From Reprogramming Biology to Next-Generation CAR Therapies

Critical Reviews in Oncology/Hematology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles